The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Immuno-Cell Therapy Market Research Report 2025

Global Immuno-Cell Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1940823

No of Pages : 91

Ask Your Query
Synopsis
Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.
The global Immuno-Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Immuno-Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immuno-Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immuno-Cell Therapy in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immuno-Cell Therapy include MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, Oxford BioTherapeutics, Fate Therapeutics, Gilead Sciences and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immuno-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Cell Therapy.
Report Scope
The Immuno-Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immuno-Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immuno-Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Segment by Type
Passive Immune (NK, LAK etc)
Active Immune
Segment by Application
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Passive Immune (NK, LAK etc)
1.2.3 Active Immune
1.3 Market by Application
1.3.1 Global Immuno-Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiovascular Disease (CVD)
1.3.4 Orthopedic
1.3.5 Wound Healing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Cell Therapy Market Perspective (2019-2030)
2.2 Immuno-Cell Therapy Growth Trends by Region
2.2.1 Global Immuno-Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immuno-Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Immuno-Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Immuno-Cell Therapy Market Dynamics
2.3.1 Immuno-Cell Therapy Industry Trends
2.3.2 Immuno-Cell Therapy Market Drivers
2.3.3 Immuno-Cell Therapy Market Challenges
2.3.4 Immuno-Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Cell Therapy Players by Revenue
3.1.1 Global Top Immuno-Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Immuno-Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-Cell Therapy Revenue
3.4 Global Immuno-Cell Therapy Market Concentration Ratio
3.4.1 Global Immuno-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Cell Therapy Revenue in 2023
3.5 Immuno-Cell Therapy Key Players Head office and Area Served
3.6 Key Players Immuno-Cell Therapy Product Solution and Service
3.7 Date of Enter into Immuno-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Cell Therapy Breakdown Data by Type
4.1 Global Immuno-Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Immuno-Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Immuno-Cell Therapy Breakdown Data by Application
5.1 Global Immuno-Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Immuno-Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immuno-Cell Therapy Market Size (2019-2030)
6.2 North America Immuno-Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immuno-Cell Therapy Market Size by Country (2019-2024)
6.4 North America Immuno-Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-Cell Therapy Market Size (2019-2030)
7.2 Europe Immuno-Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immuno-Cell Therapy Market Size by Country (2019-2024)
7.4 Europe Immuno-Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Immuno-Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immuno-Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Immuno-Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno-Cell Therapy Market Size (2019-2030)
9.2 Latin America Immuno-Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immuno-Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Immuno-Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Immuno-Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immuno-Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Immuno-Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MEDINET Co
11.1.1 MEDINET Co Company Detail
11.1.2 MEDINET Co Business Overview
11.1.3 MEDINET Co Immuno-Cell Therapy Introduction
11.1.4 MEDINET Co Revenue in Immuno-Cell Therapy Business (2019-2024)
11.1.5 MEDINET Co Recent Development
11.2 Erytech
11.2.1 Erytech Company Detail
11.2.2 Erytech Business Overview
11.2.3 Erytech Immuno-Cell Therapy Introduction
11.2.4 Erytech Revenue in Immuno-Cell Therapy Business (2019-2024)
11.2.5 Erytech Recent Development
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Detail
11.3.2 Seta Clinic Group Business Overview
11.3.3 Seta Clinic Group Immuno-Cell Therapy Introduction
11.3.4 Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2019-2024)
11.3.5 Seta Clinic Group Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Immuno-Cell Therapy Introduction
11.4.4 Takeda Revenue in Immuno-Cell Therapy Business (2019-2024)
11.4.5 Takeda Recent Development
11.5 SBI Holdings
11.5.1 SBI Holdings Company Detail
11.5.2 SBI Holdings Business Overview
11.5.3 SBI Holdings Immuno-Cell Therapy Introduction
11.5.4 SBI Holdings Revenue in Immuno-Cell Therapy Business (2019-2024)
11.5.5 SBI Holdings Recent Development
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Detail
11.6.2 Oxford BioTherapeutics Business Overview
11.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Introduction
11.6.4 Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2019-2024)
11.6.5 Oxford BioTherapeutics Recent Development
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Detail
11.7.2 Fate Therapeutics Business Overview
11.7.3 Fate Therapeutics Immuno-Cell Therapy Introduction
11.7.4 Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2019-2024)
11.7.5 Fate Therapeutics Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Immuno-Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Immuno-Cell Therapy Business (2019-2024)
11.8.5 Gilead Sciences Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Cell Therapy Introduction
11.9.4 Novartis Revenue in Immuno-Cell Therapy Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Osiris
11.10.1 Osiris Company Detail
11.10.2 Osiris Business Overview
11.10.3 Osiris Immuno-Cell Therapy Introduction
11.10.4 Osiris Revenue in Immuno-Cell Therapy Business (2019-2024)
11.10.5 Osiris Recent Development
11.11 Vericel Corporation
11.11.1 Vericel Corporation Company Detail
11.11.2 Vericel Corporation Business Overview
11.11.3 Vericel Corporation Immuno-Cell Therapy Introduction
11.11.4 Vericel Corporation Revenue in Immuno-Cell Therapy Business (2019-2024)
11.11.5 Vericel Corporation Recent Development
11.12 Fujifilm Cellular Dynamics
11.12.1 Fujifilm Cellular Dynamics Company Detail
11.12.2 Fujifilm Cellular Dynamics Business Overview
11.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Introduction
11.12.4 Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2019-2024)
11.12.5 Fujifilm Cellular Dynamics Recent Development
11.13 JCR Pharmaceuticals
11.13.1 JCR Pharmaceuticals Company Detail
11.13.2 JCR Pharmaceuticals Business Overview
11.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Introduction
11.13.4 JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2019-2024)
11.13.5 JCR Pharmaceuticals Recent Development
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Detail
11.14.2 Beike Biotechnology Business Overview
11.14.3 Beike Biotechnology Immuno-Cell Therapy Introduction
11.14.4 Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2019-2024)
11.14.5 Beike Biotechnology Recent Development
11.15 Golden Meditech
11.15.1 Golden Meditech Company Detail
11.15.2 Golden Meditech Business Overview
11.15.3 Golden Meditech Immuno-Cell Therapy Introduction
11.15.4 Golden Meditech Revenue in Immuno-Cell Therapy Business (2019-2024)
11.15.5 Golden Meditech Recent Development
11.16 Guanhao Biotech
11.16.1 Guanhao Biotech Company Detail
11.16.2 Guanhao Biotech Business Overview
11.16.3 Guanhao Biotech Immuno-Cell Therapy Introduction
11.16.4 Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2019-2024)
11.16.5 Guanhao Biotech Recent Development
11.17 Beroni Group
11.17.1 Beroni Group Company Detail
11.17.2 Beroni Group Business Overview
11.17.3 Beroni Group Immuno-Cell Therapy Introduction
11.17.4 Beroni Group Revenue in Immuno-Cell Therapy Business (2019-2024)
11.17.5 Beroni Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Immuno-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Passive Immune (NK, LAK etc)
Table 3. Key Players of Active Immune
Table 4. Global Immuno-Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Immuno-Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Immuno-Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Immuno-Cell Therapy Market Share by Region (2019-2024)
Table 8. Global Immuno-Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Immuno-Cell Therapy Market Share by Region (2025-2030)
Table 10. Immuno-Cell Therapy Market Trends
Table 11. Immuno-Cell Therapy Market Drivers
Table 12. Immuno-Cell Therapy Market Challenges
Table 13. Immuno-Cell Therapy Market Restraints
Table 14. Global Immuno-Cell Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Immuno-Cell Therapy Market Share by Players (2019-2024)
Table 16. Global Top Immuno-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Cell Therapy as of 2023)
Table 17. Ranking of Global Top Immuno-Cell Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Immuno-Cell Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Immuno-Cell Therapy Product Solution and Service
Table 21. Date of Enter into Immuno-Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Immuno-Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Immuno-Cell Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Immuno-Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Immuno-Cell Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Immuno-Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Immuno-Cell Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Immuno-Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Immuno-Cell Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Immuno-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Immuno-Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Immuno-Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Immuno-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Immuno-Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Immuno-Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Immuno-Cell Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Immuno-Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Immuno-Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Immuno-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Immuno-Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Immuno-Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Immuno-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Immuno-Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Immuno-Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. MEDINET Co Company Detail
Table 47. MEDINET Co Business Overview
Table 48. MEDINET Co Immuno-Cell Therapy Product
Table 49. MEDINET Co Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 50. MEDINET Co Recent Development
Table 51. Erytech Company Detail
Table 52. Erytech Business Overview
Table 53. Erytech Immuno-Cell Therapy Product
Table 54. Erytech Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 55. Erytech Recent Development
Table 56. Seta Clinic Group Company Detail
Table 57. Seta Clinic Group Business Overview
Table 58. Seta Clinic Group Immuno-Cell Therapy Product
Table 59. Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 60. Seta Clinic Group Recent Development
Table 61. Takeda Company Detail
Table 62. Takeda Business Overview
Table 63. Takeda Immuno-Cell Therapy Product
Table 64. Takeda Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. SBI Holdings Company Detail
Table 67. SBI Holdings Business Overview
Table 68. SBI Holdings Immuno-Cell Therapy Product
Table 69. SBI Holdings Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 70. SBI Holdings Recent Development
Table 71. Oxford BioTherapeutics Company Detail
Table 72. Oxford BioTherapeutics Business Overview
Table 73. Oxford BioTherapeutics Immuno-Cell Therapy Product
Table 74. Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 75. Oxford BioTherapeutics Recent Development
Table 76. Fate Therapeutics Company Detail
Table 77. Fate Therapeutics Business Overview
Table 78. Fate Therapeutics Immuno-Cell Therapy Product
Table 79. Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 80. Fate Therapeutics Recent Development
Table 81. Gilead Sciences Company Detail
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Immuno-Cell Therapy Product
Table 84. Gilead Sciences Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 85. Gilead Sciences Recent Development
Table 86. Novartis Company Detail
Table 87. Novartis Business Overview
Table 88. Novartis Immuno-Cell Therapy Product
Table 89. Novartis Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Osiris Company Detail
Table 92. Osiris Business Overview
Table 93. Osiris Immuno-Cell Therapy Product
Table 94. Osiris Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 95. Osiris Recent Development
Table 96. Vericel Corporation Company Detail
Table 97. Vericel Corporation Business Overview
Table 98. Vericel Corporation Immuno-Cell Therapy Product
Table 99. Vericel Corporation Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 100. Vericel Corporation Recent Development
Table 101. Fujifilm Cellular Dynamics Company Detail
Table 102. Fujifilm Cellular Dynamics Business Overview
Table 103. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product
Table 104. Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 105. Fujifilm Cellular Dynamics Recent Development
Table 106. JCR Pharmaceuticals Company Detail
Table 107. JCR Pharmaceuticals Business Overview
Table 108. JCR Pharmaceuticals Immuno-Cell Therapy Product
Table 109. JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 110. JCR Pharmaceuticals Recent Development
Table 111. Beike Biotechnology Company Detail
Table 112. Beike Biotechnology Business Overview
Table 113. Beike Biotechnology Immuno-Cell Therapy Product
Table 114. Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 115. Beike Biotechnology Recent Development
Table 116. Golden Meditech Company Detail
Table 117. Golden Meditech Business Overview
Table 118. Golden Meditech Immuno-Cell Therapy Product
Table 119. Golden Meditech Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 120. Golden Meditech Recent Development
Table 121. Guanhao Biotech Company Detail
Table 122. Guanhao Biotech Business Overview
Table 123. Guanhao Biotech Immuno-Cell Therapy Product
Table 124. Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 125. Guanhao Biotech Recent Development
Table 126. Beroni Group Company Detail
Table 127. Beroni Group Business Overview
Table 128. Beroni Group Immuno-Cell Therapy Product
Table 129. Beroni Group Revenue in Immuno-Cell Therapy Business (2019-2024) & (US$ Million)
Table 130. Beroni Group Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Immuno-Cell Therapy Market Share by Type: 2023 VS 2030
Figure 3. Passive Immune (NK, LAK etc) Features
Figure 4. Active Immune Features
Figure 5. Global Immuno-Cell Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Immuno-Cell Therapy Market Share by Application: 2023 VS 2030
Figure 7. Oncology Case Studies
Figure 8. Cardiovascular Disease (CVD) Case Studies
Figure 9. Orthopedic Case Studies
Figure 10. Wound Healing Case Studies
Figure 11. Others Case Studies
Figure 12. Immuno-Cell Therapy Report Years Considered
Figure 13. Global Immuno-Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Immuno-Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Immuno-Cell Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Immuno-Cell Therapy Market Share by Players in 2023
Figure 17. Global Top Immuno-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Cell Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Immuno-Cell Therapy Revenue in 2023
Figure 19. North America Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Immuno-Cell Therapy Market Share by Country (2019-2030)
Figure 21. United States Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Immuno-Cell Therapy Market Share by Country (2019-2030)
Figure 25. Germany Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Immuno-Cell Therapy Market Share by Region (2019-2030)
Figure 33. China Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Immuno-Cell Therapy Market Share by Country (2019-2030)
Figure 41. Mexico Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Immuno-Cell Therapy Market Share by Country (2019-2030)
Figure 45. Turkey Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Immuno-Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. MEDINET Co Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 48. Erytech Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 49. Seta Clinic Group Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 50. Takeda Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 51. SBI Holdings Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 52. Oxford BioTherapeutics Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 53. Fate Therapeutics Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 54. Gilead Sciences Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 55. Novartis Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 56. Osiris Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 57. Vericel Corporation Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 58. Fujifilm Cellular Dynamics Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 59. JCR Pharmaceuticals Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 60. Beike Biotechnology Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 61. Golden Meditech Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 62. Guanhao Biotech Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 63. Beroni Group Revenue Growth Rate in Immuno-Cell Therapy Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock